Beyond that there are fairly broad declines, with LSE Group, catering firm Compass and events and data group RELX all weighing ... along with weight-loss drug giant Novo Nordisk and German ...

As suas congéneres Pearson e Relx também registaram uma descida de ... mesmo antes da tomada de posse do novo parlamento no próximo mês, de acordo com o ministro das finanças interino do ...

RELX opened at $48.99 on Friday. Relx has a twelve month low of $40.25 and a twelve month high of $51.99. The firm has a market cap of $91.04 billion, a PE ratio of 26.34, a price-to-earnings ...

BlackRock Global Dividend Fund posted returns of -4.66% (Institutional shares) and -4.64% (Investor A shares, without sales ...

Investors with an interest in Internet - Content stocks have likely encountered both Shutterstock (SSTK) and RELX PLC (RELX). But which of these two stocks offers value investors a better bang for ...

Investing.com -- Relx Plc (LON:REL) has been upgraded to “overweight” by Barclays, reflecting confidence in the company’s resilience and growth potential amid an uncertain macroeconomic ...

Investing.com -- Novo Nordisk shares climbed more than 3% premarket on Tuesday after Hims&Hers Health announced it may no longer sell compounded versions of semaglutide, the active ingredient in ...

(Bloomberg) -- Novo Nordisk A/S shares plunged the most since December after another disappointment for the drugmaker’s next-generation shot CagriSema. The medicine helped patients with diabetes ...

The FDA today declared the national deficit of GLP-1 diet drugs at an end. Well, at least for Novo Nordisk's Ozempic and Wegovy. Novo Nordisk sales should be going up, and Hims & Hers Health's ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer. Hims & Hers Health Inc.’s stock plunged last week when the ...

Novo can now meet the demand for Ozempic and Wegovy nationwide, the Food and Drug Administration said Friday. The ruling shows Novo’s confidence that the supply of Ozempic will be stable for now.